In brief
The Advisory Committee on Immunization Practices, led by Health Secretary Kennedy, is meeting to vote on critical vaccination policies, including hepatitis B and the MMRV shot. Concerns arise regarding the proposed rollback of the hepatitis B vaccine at birth, with health leaders questioning the rationale behind the changes. Public health officials express alarm over the impact these decisions could have on childhood vaccination rates and trust in vaccines.
ATLANTA (AP) — Health Secretary Robert F. Kennedy Jr. convenes his new vaccine advisory committee to deliberate on COVID-19, hepatitis B, and chickenpox vaccinations. The committee's meeting will take place over two days, with voting expected on various proposals.
Among the key issues to be discussed is a potential rollback of the longstanding recommendation for all U.S. infants to receive the hepatitis B vaccine at birth. Several health authorities, including the American Academy of Pediatrics, endorse this practice due to its success in reducing liver disease rates among children.
“It’s perplexing why we would consider withdrawing this guidance when we’ve achieved significant progress,” voiced Dr. Mysheika Roberts, director of health for Columbus, Ohio, who previously served on the committee but was dismissed by Kennedy. “If the system is working, there's no need for drastic changes.”
The Advisory Committee is also set to evaluate the MMRV (measles, mumps, rubella, and varicella) combination shot. Chair Martin Kulldorff has proposed that this vaccine should not be given to children younger than four, citing data on potential fever-related seizures associated with the first dose.
Health experts express concerns that this potential change may confuse parents and undermine vaccination efforts. Many say that there isn't sufficient new safety data justifying such revisions to long-standing recommendations.
The panel, highly influential on immunization practices, will soon make recommendations that the CDC usually follows, shaping public health policy across the nation. The new committee, criticized for its anti-vaccine perspectives, has stirred significant concern among medical professionals and public health leaders.
As discussions proceed, health groups are reiterating the importance of maintaining robust vaccination programs to safeguard public health, especially in light of recent legislative efforts across several states aimed at ensuring access to vaccines.
